Author: Ken Dropiewski

Cardiac Atrophy Findings May Set Course for Preventing Harm from Long Space Flights

Team led by scientists at Cincinnati Children’s discover molecular process behind dangerous loss of heart muscle CINCINNATI, June 24, 2021 /PRNewswire/ — In many situations, heart muscle cells do not respond to external stresses in the same ways that skeletal muscle cells do. But under some conditions, heart and skeletal muscles can both […]

OMRON Healthcare and Kyoto University Collaborative Research Program “Healthcare Medical AI” to prevent the events of cardiovascular diseases with AI and home measurement data

KYOTO, Japan, June 24, 2021 /PRNewswire/ — OMRON Healthcare Co., Ltd. (Head Office: Muko-city, Kyoto, Japan, President & CEO: Isao Ogino) and Kyoto University (Sakyo-ku, Kyoto-city Kyoto, Japan, President: Nagahiro Minato) today announced a new Collaborative Research Program called “Healthcare Medical AI” (Principal Researcher: Yasushi Okuno, Ph.D., Prof., Department of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University) to use […]

RapidAI Launches Rapid Workflow for Pulmonary Embolism (PE)

Developed in partnership with Penumbra, Inc., Rapid Workflow for PE supports faster team activation to accelerate PE care and drive better patient outcomes SAN MATEO, Calif., June 24, 2021 /PRNewswire/ — RapidAI, leading the next evolution of clinical decision making and patient workflow, today announced the availability of Rapid Workflow for PE, a mobile […]

Peijia Medical’s Jasper® SS Detachable Coil Receives NMPA Approval for Commercialization

SUZHOU, China, June 24, 2021 /PRNewswire/ — On June 15, 2021, Jasper® SS—a new detachable coil independently developed by Achieva Medical, subsidiary of Peijia Medical (9996.HK)—was approved by the National Medical Products Administration (“NMPA”) for commercialization (registration number GXZZ 20113130440). In the field of neurointervention, embolization coils are designed to be as thin as […]

Aerami Therapeutics Initiates Dosing in Phase 1 Trial of AER-901, Its Proprietary Inhaled Imatinib for the Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) affects almost 68,000 patients worldwide, with treatment limited to vasodilators, none of which are disease-modifying Dosing of patients in Phase 1 trial is currently ongoing with results expected later this year Plans to enter Phase 2/3 Trials in early 2022 DURHAM, N.C., June 24, 2021 (GLOBE […]

RapidPulse Launches With $15 Million Series A Financing for Ischemic Stroke Therapy

Industry Veterans Join Team to Support the Development of Novel Cyclic Aspiration System for Ischemic Stroke MIAMI, June 23, 2021 (GLOBE NEWSWIRE) — RapidPulse, Inc., a privately-held medical device company developing a novel aspiration system to treat ischemic stroke, today announced the closing of a $15 million Series A financing. […]

CardioFocus Receives Regulatory Approval to Market HeartLight X3 System in Japan

– Japan Lifeline will distribute CardioFocus’ innovative catheter ablation technology for pulmonary vein isolation, the gold standard treatment for atrial fibrillation – Regulatory approval comes as use of catheter ablation technologies for AFib is increasing in Japan at a substantial rate MARLBOROUGH, Mass., June 23, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device […]

PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing Chemotherapy

MORRISVILLE, N.C., June 23, 2021 /PRNewswire/ — A new pivotal article validated Myocardial Solutions technology MyoStrain® (fSENC) for the early detection and prediction of cardiotoxicity (heart damage). The article was published in Circulation: Cardiovascular Imaging and highlights MyoStrain as an accurate and sensitive management tool that may help clinicians protect cancer patient heart health during […]

JanOne Readies Clinical Supply of Lead Product Candidate JAN101 for Distribution to Phase 2b Trial Sites

Company Fully Prepared to Commence Phase 2b Trials of JAN101 for Peripheral Artery Disease (PAD) as Soon as New Protocol is Approved by the FDA LAS VEGAS, June 23, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, […]